WellCare Health Plans, Inc. (NYSE:WCG) EVP Anat Hakim sold 1,647 shares of the company’s stock in a transaction dated Friday, November 30th. The shares were sold at an average price of $256.24, for a total transaction of $422,027.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Shares of NYSE:WCG opened at $244.15 on Friday. The company has a market capitalization of $12.61 billion, a P/E ratio of 28.66, a PEG ratio of 1.40 and a beta of 1.18. WellCare Health Plans, Inc. has a fifty-two week low of $187.06 and a fifty-two week high of $324.99. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.32 and a current ratio of 1.32.
WellCare Health Plans (NYSE:WCG) last issued its earnings results on Tuesday, October 30th. The company reported $3.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.09 by $0.24. The firm had revenue of $5.06 billion for the quarter, compared to analysts’ expectations of $5.06 billion. WellCare Health Plans had a net margin of 2.38% and a return on equity of 15.45%. The firm’s revenue was up 14.9% compared to the same quarter last year. During the same quarter last year, the company earned $4.08 earnings per share. As a group, analysts predict that WellCare Health Plans, Inc. will post 11.01 earnings per share for the current fiscal year.
A number of equities research analysts recently issued reports on WCG shares. Argus upped their price objective on shares of WellCare Health Plans from $265.00 to $360.00 and gave the company a “buy” rating in a report on Friday, August 31st. Morgan Stanley increased their target price on shares of WellCare Health Plans from $280.00 to $330.00 and gave the stock an “equal weight” rating in a research note on Wednesday, September 5th. BMO Capital Markets set a $345.00 target price on shares of WellCare Health Plans and gave the stock a “buy” rating in a research note on Friday, September 14th. Cantor Fitzgerald increased their price target on shares of WellCare Health Plans from $292.00 to $330.00 and gave the stock an “overweight” rating in a research report on Monday, September 17th. Finally, Barclays reissued a “buy” rating and set a $325.00 price target on shares of WellCare Health Plans in a research report on Tuesday, September 18th. Three research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company. WellCare Health Plans has an average rating of “Buy” and an average target price of $305.20.
ILLEGAL ACTIVITY NOTICE: This piece of content was published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://dakotafinancialnews.com/2018/12/07/wellcare-health-plans-inc-wcg-evp-sells-422027-28-in-stock.html.
WellCare Health Plans Company Profile
WellCare Health Plans, Inc provides managed care services for government-sponsored health care programs. It operates through three segments: Medicaid Health Plans, Medicare Health Plans, and Medicare PDPs. The Medicaid Health Plans segment offers plans for beneficiaries of temporary assistance for needy families, supplemental security income, and aged blind and disabled residents; and other state-based programs, such as children's health insurance programs and long-term services and supports for qualifying families who are not eligible for Medicaid.
Recommended Story: What is an investor looking for in an SEC filing?
Receive News & Ratings for WellCare Health Plans Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WellCare Health Plans and related companies with MarketBeat.com's FREE daily email newsletter.